Microbiomics in Clinical Trials Training Course (ONLINE EVENT: Sept 14, 2026)

The microbiome offers untapped potential as a therapeutic target in disease management. Key market opportunities lie in developing standardized methodologies, advanced bioinformatics solutions for big data, and establishing best practices for clinical trials in microbiomics to enhance its clinical relevancy.


Dublin, May 06, 2026 (GLOBE NEWSWIRE) -- The "Microbiomics in Clinical Trials (Sept 14, 2026)" training has been added to ResearchAndMarkets.com's offering.

The microbiome plays an important role in many diseases and holds promise of being a therapeutic target, or key, of high clinical relevance.

However, the metholodogy of the science of microbiomics is very unlike what is typically used in clinical trials: big data, computationally-demanding bioinformatics, highly multivariate results, skewed distributions, complex assumptions. In addition, the field is held back by a lack of standardisation.

What is the clinical relevance of the microbiome? What is the current status of microbiomics in clinical trials? What interpretational pitfalls should one be wary of in the field of microbiomics? How can current best practices best be applied in a microbiome context? How does one validate the results of microbiomics?

These are some of the questions that this course will seek to shed some light on.

Who Should Attend:

This course intends to bridge the gap between the science of microbiomics and the conduct of clinical trials. The course's intended audience is anyone who wishes to conduct or contribute to a clinical trial that uses microbiome science.

  • Microbiome scientists
  • Bioinformaticians
  • Clinical trial managers
  • QA professionals
  • RA professionals

Key Topics Covered:

  • An introduction to the microbiome and its broad clinical relevance
  • The basics of microbiomics methodology and data
  • Microbiomics in clinical trials to date
  • Data integrity of big data
  • Validation and standardization of microbiomics methods

Speakers

Nikolaj Sorensen

Nikolaj Sorensen holds a MSc in biology and PhD in microbial ecology form the University of Copenhagen. He has worked with microbiomics for 10 years, both executing and leading laboratory and bioinformatic efforts, and has authored several papers on the subject and worked on several clinical trials. Currently, Nikolaj Sorensen focuses on bringing microbiomics into medicine, facilitating that process from a QA perspective.

For more information about this training visit https://www.researchandmarkets.com/r/vqignm

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data

GlobeNewswire

Recommended Reading